US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

ENTA Enanta Pharmaceuticals Inc

12.13

-0.93 (-7.12%)

17 May 2024 - Cerrado

Retrasado por 15 minutos

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Enanta Pharmaceuticals (NASDAQ:ENTA)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Enanta Pharmaceuticals.

Enanta Pharmaceuticals (NASDAQ:ENTA)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Enanta Pharmaceuticals.

Noticias sobre Enanta Pharmaceuticals Inc ENTA

Form S-8 - Securities to be offered to employees in employee benefit plans
Miércoles 8 de Mayo 2024 (1 semana hace) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Miércoles 8 de Mayo 2024 (1 semana hace) • Edgar (US Regulatory)

Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Martes 7 de Mayo 2024 (2 semanas hace) • Business Wire

Form 8-K - Current report
Lunes 6 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Lunes 6 de Mayo 2024 (2 semanas hace) • Business Wire

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Martes 30 de Abril 2024 (3 semanas hace) • Business Wire

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Martes 30 de Abril 2024 (3 semanas hace) • Business Wire

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Lunes 29 de Abril 2024 (3 semanas hace) • Business Wire

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Miércoles 17 de Abril 2024 (1 mes hace) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 8 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 8 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 8 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Más de Enanta Pharmaceuticals Inc Artículos de Noticias

OMNOVA Solutions

Amundi icpr Euro Corpora...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones